Results 71 to 80 of about 19,000 (208)

Factors associated with the quality of life of subjects with Parkinson's disease and burden on their caregivers

open access: yesNeurología (English Edition), 2015
Introduction: Parkinson's disease affects the quality of life of the individual with the disease in addition to creating a burden on the caregiver. Factors related to these effects include motor and non-motor aspects of the disease, as well as traits ...
M. Rodríguez-Violante   +4 more
doaj   +1 more source

Derivados de 1,4,5-dibenzo[b,f]tiadiazepinas 5,6-dihidro y su uso en el tratamiento de enfermedades neurodegenerativas [PDF]

open access: yes, 2008
Derivados de 1,4,5-dibenzo[b,f]tiadiazepinas 5,6-dihidro y su uso en el tratamiento de enfermedades neurodegenerativas. Compuestos químicos derivados del sistema heterocíclico 1,4,5-dibenzo[b,f]tiadiazepinas 5,6-dihidro y su uso como composiciones ...
Conde, Santiago   +5 more
core  

Muscle MRI and Muscle Ultrasound Applications in MND/ALS: Academic Insights and Clinical Opportunities

open access: yesEuropean Journal of Neurology, Volume 33, Issue 3, March 2026.
ABSTRACT Background There is an unmet need for the clinically relevant ALS biomarkers to facilitate an accurate diagnosis in suspected cases, monitor disease progression and evaluate response to therapy in clinical trials. While the MND/ALS literature is dominated by innovative brain studies, motor disability in ALS is primarily driven by neurogenic ...
Alison Toomey   +4 more
wiley   +1 more source

Heterocyclic GSK-3 allosteric modulators [PDF]

open access: yes, 2011
[ES] La presente invención se refiere a derivados heterocíclicos de quinolinas sustituidas como inhibidores alostéricos del enzima glucógeno sintasa quinasa 3 (GSK-3).
Gil, Carmen   +4 more
core  

Frailty and Health Outcomes in People 65 Years or Older Living With Dementia: A Systematic Review of the Literature

open access: yesJournal of the American Geriatrics Society, Volume 74, Issue 3, Page 854-867, March 2026.
ABSTRACT Introduction Although frailty is considered a potentially modifiable risk factor for dementia, its influence on health outcomes in individuals with established dementia remains unclear. This study aims to systematize the current evidence to understand the impact of frailty on the development of adverse outcomes in older adults with dementia ...
Miguel German Borda   +11 more
wiley   +1 more source

Alzheimer’s disease as an inflammatory disease

open access: yesBiomolecular Concepts, 2017
Alzheimer’s disease (AD) is a neurodegenerative condition characterized by the formation of amyloid-β plaques, aggregated and hyperphosphorylated tau protein, activated microglia and neuronal cell death, ultimately leading to progressive dementia.
Bolós Marta   +2 more
doaj   +1 more source

The involvement of cholinergic neurons in the spreading of tau pathology

open access: yesFrontiers in Neurology, 2013
Long time ago, it was described the selective loss of cholinergic neurons during the development of Alzheimer disease. Recently, it has been suggested that tau protein may play a role in that loss of cholinergic neurons through a mechanism involving the ...
Diana eSimon   +5 more
doaj   +1 more source

Bases Moleculares de la Enfermedad de Alzheimer [PDF]

open access: yes, 2018
La enfermedad de Alzheimer es el tipo más frecuente de demencia senil y constituye un grave problema de salud pública desde hace varios años, con una importancia creciente conforme aumenta la edad media y la esperanza de vida de la población.
Gutiérrez Antoñanzas, Juan Carlos
core  

Enfermedades neurodegenerativas: Alzehimer-Parquinson

open access: yes, 2021
Antes de comenzar con la descripción del Síndrome de Alzheimer y la enfermedad de Parkinson,debemos mencionar algunas generalidades comunes a las enfermedades neurodegenerativas.Estas son un grupo de enfermedades que afectan al sistema nervioso central, siendo doscaracterísticas importantes la naturaleza degenerativa y el curso crónico de las mismas ...
openaire   +1 more source

Insertos intranasales para dirigir moléculas activas al sistema nervioso central [PDF]

open access: yes, 2019
Con motivo del auge actual acerca de los avances producidos en el tratamiento de las enfermedades neurodegenerativas, se están abarcando otras estrategias alternativas focalizadas hacia la consecución de una mayor efectividad de los tratamientos.
Martos Carrasco, Laura
core  

Home - About - Disclaimer - Privacy